Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Subcutaneous Injections of Interleukin-2 for the Treatment of Mycosis Fungoides or the Sezary Syndrome

NCT00005788 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00005788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Subcutaneous Injections of Interleukin-2 for the Treatment of Mycosis Fungoides or the Sezary Syndrome
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 1997
Completion date
January 31, 2002
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma